This clinical trial evaluates the characteristics of oral nicotine pouches (ONPs) to determine if they are a comparable substitute to cigarette or smokeless tobacco (ST) products. ONPs contain nicotine but no tobacco and are used primarily by adult tobacco uses in the United States (US). ONPs are recognized by the Food and Drug Administration as having lower risk than combustible cigarettes and are approved as a modified risk tobacco product. While ONPs have lower toxic risk than other tobacco products, acute and longer term harm related to their use has not been studied. Information gathered from this study may identify product characteristics of ONPs that improve successful switching from high-risk cigarettes or ST to lower risk ONPs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Increased nicotine delivery
Timeframe: Up to 3 months
Liking
Timeframe: Up to 3 months
Craving/withdrawal suppression
Timeframe: Up to 3 months
Rate of switching to ONP
Timeframe: Up to 3 months
Rate of switching to ONPs
Timeframe: Up to 3 months
The Ohio State University Comprehensive Cancer Center